English

INTERNATIONAL BIOCHEMICAL INDUSTRIES INC

EDGAR

Filing amendment (10QSB/A) · filed 2003-03-03

22 filing records in this dataset, filed from 1998-11-16 to 2003-03-03. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

74.4 thousand USD

2002-12-31 · USD

Exact inputs and evidence

Revenue: 74383 USD Source

Operating margin

-1,561.78%

2002-12-31 · %

Exact inputs and evidence

Operating Income: -1161701 USD Source
Revenue: 74383 USD Source

Operating cash flow

-13.9 thousand USD

2002-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -39258 USD Source
Operating Cash Flow: -25353 USD Source

Cash and cash equivalents: 636 USD 2002-12-31 Source
Exact value

636 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1 million USD

2002-01-01 – 2002-12-31

Exact inputs and evidence

Revenue: 841054 USD · 2002-01-01 – 2002-03-31 Source
Revenue: 1937122 USD · 2001-07-01 – 2002-06-30 Source
Revenue: 1955201 USD · 2001-07-01 – 2002-03-31 Source
Revenue: 103286 USD · 2002-07-01 – 2002-09-30 Source
Revenue: 74383 USD · 2002-10-01 – 2002-12-31 Source

Net income

-7.97 million USD

2002-01-01 – 2002-12-31

Exact inputs and evidence

Net income: -918153 USD · 2002-01-01 – 2002-03-31 Source
Net income: -6628111 USD · 2001-07-01 – 2002-06-30 Source
Net income: -3077092 USD · 2001-07-01 – 2002-03-31 Source
Net income: -879792 USD · 2002-07-01 – 2002-09-30 Source
Net income: -2616989 USD · 2002-10-01 – 2002-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-03-03.

Financial data available through: 2002-06-30.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2002-06-30
Operating income: 5 of 11 periods available· newest 2002-06-30
Net income: 5 of 11 periods available· newest 2002-06-30
Operating cash flow: 5 of 11 periods available· newest 2002-06-30
Capital expenditure: 5 of 11 periods available· newest 2002-06-30
Total assets: 3 of 11 periods available· newest 2002-06-30
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 2002-06-30
Current liabilities: 5 of 11 periods available· newest 2002-06-30
Cash and cash equivalents: 5 of 11 periods available· newest 2002-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+29.1%

Prior period

USD 1.5 million

2000-07-01 – 2001-06-30
Current period

USD 1.94 million

2001-07-01 – 2002-06-30

Exact inputs and evidence

1937122 − 1500648 = 436474 USD

1500648 USD · 2000-07-01 – 2001-06-30
Inspect prior input Prior source
1937122 USD · 2001-07-01 – 2002-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2002-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Year-over-year change in Revenue: 436474 USD Concept: fundies:Revenue Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1937122 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2331 Input fundies:Revenue: 1500648 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2331
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 12.77 million

Prior period

−USD 19.4 million

2000-07-01 – 2001-06-30
Current period

−USD 6.63 million

2001-07-01 – 2002-06-30

Exact inputs and evidence

-6628111 − -19401674 = 12773563 USD

-19401674 USD · 2000-07-01 – 2001-06-30
Inspect prior input Prior source
-6628111 USD · 2001-07-01 – 2002-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2002-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Year-over-year change in Net income: 12773563 USD Concept: fundies:NetIncome Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6628111 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2366 Input fundies:NetIncome: -19401674 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2366
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 11.17 million

Prior period

−USD 12.75 million

2000-07-01 – 2001-06-30
Current period

−USD 1.58 million

2001-07-01 – 2002-06-30

Exact inputs and evidence

-1578160 − -12751504 = 11173344 USD

-12751504 USD · 2000-07-01 – 2001-06-30
Inspect prior input Prior source
-1578160 USD · 2001-07-01 – 2002-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2002-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Year-over-year change in Operating cash flow: 11173344 USD Concept: fundies:OperatingCashFlow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1578160 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2603 Input fundies:OperatingCashFlow: -12751504 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2603
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+96.5%

Prior period

USD 45,247

2000-07-01 – 2001-06-30
Current period

USD 88,932

2001-07-01 – 2002-06-30

Exact inputs and evidence

88932 − 45247 = 43685 USD

45247 USD · 2000-07-01 – 2001-06-30
Inspect prior input Prior source
88932 USD · 2001-07-01 – 2002-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2002-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Year-over-year change in Capital expenditure: 43685 USD Concept: fundies:CapitalExpenditure Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 88932 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2608 Input fundies:CapitalExpenditure: 45247 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2608
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2002 2001-07-01 – 2002-06-30

Revenue USD 1.94 million 100% of revenue
Operating costs Derived USD 6.91 million 357% of revenue
Operating income −USD 4.98 million −257% of revenue
Tax, interest and other Derived USD 1.65 million 85% of revenue
Net income −USD 6.63 million −342% of revenue

Cash

Operating cash flow −USD 1.58 million −81% of revenue
Capital expenditure USD 88,932 4.6% of revenue
Free cash flow Derived −USD 1.67 million −86% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 415% of revenue.
1999 Operating loss: operating costs were 1,230% of revenue.
2000 Operating loss: operating costs were 1,178% of revenue.
2001 Operating loss: operating costs were 590% of revenue.
2002 Operating loss: operating costs were 357% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1997-07-01 – 1998-06-30	462471	1919567 Derived	-1457096	14833 Derived	-1471929	-1289785 Derived	Source 1997-07-01 – 1998-06-30: 462471 USD Inspect Revenue Open source 1997-07-01 – 1998-06-30: -1457096 USD Inspect Operating Income Open source 1997-07-01 – 1998-06-30: -1471929 USD Inspect Net Income Open source 1997-07-01 – 1998-06-30: -1213305 USD Inspect Operating Cash Flow Open source 1997-07-01 – 1998-06-30: 76480 USD Inspect Capital Expenditure Open source
1999 1998-07-01 – 1999-06-30	305336	3755126 Derived	-3449790	-160174 Derived	-3289616	-3249392 Derived	Source 1998-07-01 – 1999-06-30: 305336 USD Inspect Revenue Open source 1998-07-01 – 1999-06-30: -3449790 USD Inspect Operating Income Open source 1998-07-01 – 1999-06-30: -3289616 USD Inspect Net Income Open source 1998-07-01 – 1999-06-30: -3123488 USD Inspect Operating Cash Flow Open source 1998-07-01 – 1999-06-30: 125904 USD Inspect Capital Expenditure Open source
2000 1999-07-01 – 2000-06-30	935669	11024456 Derived	-10088787	-138003 Derived	-9950784	-24159567 Derived	Source 1999-07-01 – 2000-06-30: 935669 USD Inspect Revenue Open source 1999-07-01 – 2000-06-30: -10088787 USD Inspect Operating Income Open source 1999-07-01 – 2000-06-30: -9950784 USD Inspect Net Income Open source 1999-07-01 – 2000-06-30: -19027921 USD Inspect Operating Cash Flow Open source 1999-07-01 – 2000-06-30: 5131646 USD Inspect Capital Expenditure Open source
2001 2000-07-01 – 2001-06-30	1500648	8856521 Derived	-7355873	12045801 Derived	-19401674	-12796751 Derived	Source 2000-07-01 – 2001-06-30: 1500648 USD Inspect Revenue Open source 2000-07-01 – 2001-06-30: -7355873 USD Inspect Operating Income Open source 2000-07-01 – 2001-06-30: -19401674 USD Inspect Net Income Open source 2000-07-01 – 2001-06-30: -12751504 USD Inspect Operating Cash Flow Open source 2000-07-01 – 2001-06-30: 45247 USD Inspect Capital Expenditure Open source
2002 2001-07-01 – 2002-06-30	1937122	6914574 Derived	-4977452	1650659 Derived	-6628111	-1667092 Derived	Source 2001-07-01 – 2002-06-30: 1937122 USD Inspect Revenue Open source 2001-07-01 – 2002-06-30: -4977452 USD Inspect Operating Income Open source 2001-07-01 – 2002-06-30: -6628111 USD Inspect Net Income Open source 2001-07-01 – 2002-06-30: -1578160 USD Inspect Operating Cash Flow Open source 2001-07-01 – 2002-06-30: 88932 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.9M 2002

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-06-30	Revenue	462471	Revenue: 462471 Open source
19991999-06-30	Revenue	305336	Revenue: 305336 Open source
20002000-06-30	Revenue	935669	Revenue: 935669 Open source
20012001-06-30	Revenue	1500648	Revenue: 1500648 Open source
20022002-06-30	Revenue	1937122	Revenue: 1937122 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

29.1% 2002

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-06-30	Year over year	No prior comparable period	Revenue: 462471 Open source
19991999-06-30	Year over year	-34%	Revenue: 305336 Open source Revenue: 462471 Open source
20002000-06-30	Year over year	206.4%	Revenue: 935669 Open source Revenue: 305336 Open source
20012001-06-30	Year over year	60.4%	Revenue: 1500648 Open source Revenue: 935669 Open source
20022002-06-30	Year over year	29.1%	Revenue: 1937122 Open source Revenue: 1500648 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -257% 2002

Net margin -342.2% 2002

Free cash flow margin -86.1% 2002

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-06-30	Operating margin	-315.1%	Operating Income: -1457096 Open source Revenue: 462471 Open source
19991999-06-30	Operating margin	-1,129.8%	Operating Income: -3449790 Open source Revenue: 305336 Open source
20002000-06-30	Operating margin	-1,078.2%	Operating Income: -10088787 Open source Revenue: 935669 Open source
20012001-06-30	Operating margin	-490.2%	Operating Income: -7355873 Open source Revenue: 1500648 Open source
20022002-06-30	Operating margin	-257%	Operating Income: -4977452 Open source Revenue: 1937122 Open source
19981998-06-30	Net margin	-318.3%	Net Income: -1471929 Open source Revenue: 462471 Open source
19991999-06-30	Net margin	-1,077.4%	Net Income: -3289616 Open source Revenue: 305336 Open source
20002000-06-30	Net margin	-1,063.5%	Net Income: -9950784 Open source Revenue: 935669 Open source
20012001-06-30	Net margin	-1,292.9%	Net Income: -19401674 Open source Revenue: 1500648 Open source
20022002-06-30	Net margin	-342.2%	Net Income: -6628111 Open source Revenue: 1937122 Open source
19981998-06-30	Free cash flow margin	-278.9%	Revenue: 462471 Open source Operating Cash Flow: -1213305 Open source Capital Expenditure: 76480 Open source
19991999-06-30	Free cash flow margin	-1,064.2%	Revenue: 305336 Open source Operating Cash Flow: -3123488 Open source Capital Expenditure: 125904 Open source
20002000-06-30	Free cash flow margin	-2,582.1%	Revenue: 935669 Open source Operating Cash Flow: -19027921 Open source Capital Expenditure: 5131646 Open source
20012001-06-30	Free cash flow margin	-852.7%	Revenue: 1500648 Open source Operating Cash Flow: -12751504 Open source Capital Expenditure: 45247 Open source
20022002-06-30	Free cash flow margin	-86.1%	Revenue: 1937122 Open source Operating Cash Flow: -1578160 Open source Capital Expenditure: 88932 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.6M 2002

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-06-30	Operating cash flow	-1213305	Operating Cash Flow: -1213305 Open source
19991999-06-30	Operating cash flow	-3123488	Operating Cash Flow: -3123488 Open source
20002000-06-30	Operating cash flow	-19027921	Operating Cash Flow: -19027921 Open source
20012001-06-30	Operating cash flow	-12751504	Operating Cash Flow: -12751504 Open source
20022002-06-30	Operating cash flow	-1578160	Operating Cash Flow: -1578160 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.7M 2002

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-06-30	Free cash flow	-1289785	Operating Cash Flow: -1213305 Open source Capital Expenditure: 76480 Open source
19991999-06-30	Free cash flow	-3249392	Operating Cash Flow: -3123488 Open source Capital Expenditure: 125904 Open source
20002000-06-30	Free cash flow	-24159567	Operating Cash Flow: -19027921 Open source Capital Expenditure: 5131646 Open source
20012001-06-30	Free cash flow	-12796751	Operating Cash Flow: -12751504 Open source Capital Expenditure: 45247 Open source
20022002-06-30	Free cash flow	-1667092	Operating Cash Flow: -1578160 Open source Capital Expenditure: 88932 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-06-30	Liabilities / assets	Not reported	Total Assets: 437623 Open source
1999-06-30	Liabilities / assets	Not reported	Total Assets: 8223743 Open source
2000-06-30	Liabilities / assets	Not reported	No source recorded
2001-06-30	Liabilities / assets	Not reported	No source recorded
2002-06-30	Liabilities / assets	Not reported	Total Assets: 574609 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.08× 2002

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19981998-06-30	Current assets / current liabilities	0.21×	Current Assets: 272001 Open source Current Liabilities: 1298276 Open source
19991999-06-30	Current assets / current liabilities	9.19×	Current Assets: 7827050 Open source Current Liabilities: 851845 Open source
20002000-06-30	Current assets / current liabilities	1.4×	Current Assets: 6659407 Open source Current Liabilities: 4752109 Open source
20012001-06-30	Current assets / current liabilities	0.28×	Current Assets: 1460720 Open source Current Liabilities: 5169545 Open source
20022002-06-30	Current assets / current liabilities	0.08×	Current Assets: 381922 Open source Current Liabilities: 4649548 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1997-07-01 – 1998-06-30	−USD 1.47 million Exact value Exact value: -1471929 USD 1997-07-01 – 1998-06-30: -1471929 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 1998-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Net Income: -1471929 USD Concept: fundies:NetIncome Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ANetIncome&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:NetIncome: -1471929 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0000950144-99-011505.txt#1939 The citation records this snapshot. The page link may show a newer release later.	−USD 1.21 million Exact value Exact value: -1213305 USD 1997-07-01 – 1998-06-30: -1213305 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 1998-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Operating Cash Flow: -1213305 USD Concept: fundies:OperatingCashFlow Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3AOperatingCashFlow&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1213305 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0000950144-99-011505.txt#1955 The citation records this snapshot. The page link may show a newer release later.	USD 76,480 Exact value Exact value: 76480 USD 1997-07-01 – 1998-06-30: 76480 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 1998-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Capital Expenditure: 76480 USD Concept: fundies:CapitalExpenditure Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ACapitalExpenditure&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 76480 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0000950144-99-011505.txt#1958 The citation records this snapshot. The page link may show a newer release later.	−USD 1.29 million Calculation and evidence -1213305 − 76480 USD Exact free cash flow: -1289785 USD 1997-07-01 – 1998-06-30: -1213305 USD · Inspect Operating Cash Flow · Source 1997-07-01 – 1998-06-30: 76480 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 1998-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Free cash flow: -1289785 USD Concept: free-cash-flow Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1213305 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0000950144-99-011505.txt#1955 Input fundies:CapitalExpenditure: 76480 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0000950144-99-011505.txt#1958 The citation records this snapshot. The page link may show a newer release later.
1999 1998-07-01 – 1999-06-30	−USD 3.29 million Exact value Exact value: -3289616 USD 1998-07-01 – 1999-06-30: -3289616 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 1999-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Net Income: -3289616 USD Concept: fundies:NetIncome Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ANetIncome&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:NetIncome: -3289616 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500011.txt#612 The citation records this snapshot. The page link may show a newer release later.	−USD 3.12 million Exact value Exact value: -3123488 USD 1998-07-01 – 1999-06-30: -3123488 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 1999-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Operating Cash Flow: -3123488 USD Concept: fundies:OperatingCashFlow Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3AOperatingCashFlow&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3123488 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500011.txt#632 The citation records this snapshot. The page link may show a newer release later.	USD 125,904 Exact value Exact value: 125904 USD 1998-07-01 – 1999-06-30: 125904 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 1999-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Capital Expenditure: 125904 USD Concept: fundies:CapitalExpenditure Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ACapitalExpenditure&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 125904 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500011.txt#636 The citation records this snapshot. The page link may show a newer release later.	−USD 3.25 million Calculation and evidence -3123488 − 125904 USD Exact free cash flow: -3249392 USD 1998-07-01 – 1999-06-30: -3123488 USD · Inspect Operating Cash Flow · Source 1998-07-01 – 1999-06-30: 125904 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 1999-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Free cash flow: -3249392 USD Concept: free-cash-flow Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3123488 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500011.txt#632 Input fundies:CapitalExpenditure: 125904 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500011.txt#636 The citation records this snapshot. The page link may show a newer release later.
2000 1999-07-01 – 2000-06-30	−USD 9.95 million Exact value Exact value: -9950784 USD 1999-07-01 – 2000-06-30: -9950784 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2000-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Net Income: -9950784 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ANetIncome&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:NetIncome: -9950784 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500221.txt#1707 The citation records this snapshot. The page link may show a newer release later.	−USD 19.03 million Exact value Exact value: -19027921 USD 1999-07-01 – 2000-06-30: -19027921 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2000-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Operating Cash Flow: -19027921 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3AOperatingCashFlow&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19027921 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500221.txt#1730 The citation records this snapshot. The page link may show a newer release later.	USD 5.13 million Exact value Exact value: 5131646 USD 1999-07-01 – 2000-06-30: 5131646 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2000-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Capital Expenditure: 5131646 USD Concept: fundies:CapitalExpenditure Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ACapitalExpenditure&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5131646 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500221.txt#1734 The citation records this snapshot. The page link may show a newer release later.	−USD 24.16 million Calculation and evidence -19027921 − 5131646 USD Exact free cash flow: -24159567 USD 1999-07-01 – 2000-06-30: -19027921 USD · Inspect Operating Cash Flow · Source 1999-07-01 – 2000-06-30: 5131646 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2000-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Free cash flow: -24159567 USD Concept: free-cash-flow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19027921 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500221.txt#1730 Input fundies:CapitalExpenditure: 5131646 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001015769-01-500221.txt#1734 The citation records this snapshot. The page link may show a newer release later.
2001 2000-07-01 – 2001-06-30	−USD 19.4 million Exact value Exact value: -19401674 USD 2000-07-01 – 2001-06-30: -19401674 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2001-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Net Income: -19401674 USD Concept: fundies:NetIncome Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ANetIncome&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:NetIncome: -19401674 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2366 The citation records this snapshot. The page link may show a newer release later.	−USD 12.75 million Exact value Exact value: -12751504 USD 2000-07-01 – 2001-06-30: -12751504 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2001-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Operating Cash Flow: -12751504 USD Concept: fundies:OperatingCashFlow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3AOperatingCashFlow&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12751504 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2603 The citation records this snapshot. The page link may show a newer release later.	USD 45,247 Exact value Exact value: 45247 USD 2000-07-01 – 2001-06-30: 45247 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2001-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Capital Expenditure: 45247 USD Concept: fundies:CapitalExpenditure Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ACapitalExpenditure&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 45247 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2608 The citation records this snapshot. The page link may show a newer release later.	−USD 12.8 million Calculation and evidence -12751504 − 45247 USD Exact free cash flow: -12796751 USD 2000-07-01 – 2001-06-30: -12751504 USD · Inspect Operating Cash Flow · Source 2000-07-01 – 2001-06-30: 45247 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2001-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Free cash flow: -12796751 USD Concept: free-cash-flow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12751504 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2603 Input fundies:CapitalExpenditure: 45247 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2608 The citation records this snapshot. The page link may show a newer release later.
2002 2001-07-01 – 2002-06-30	−USD 6.63 million Exact value Exact value: -6628111 USD 2001-07-01 – 2002-06-30: -6628111 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2002-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Net Income: -6628111 USD Concept: fundies:NetIncome Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ANetIncome&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:NetIncome: -6628111 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2366 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Exact value Exact value: -1578160 USD 2001-07-01 – 2002-06-30: -1578160 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2002-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Operating Cash Flow: -1578160 USD Concept: fundies:OperatingCashFlow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3AOperatingCashFlow&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1578160 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2603 The citation records this snapshot. The page link may show a newer release later.	USD 88,932 Exact value Exact value: 88932 USD 2001-07-01 – 2002-06-30: 88932 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2002-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Capital Expenditure: 88932 USD Concept: fundies:CapitalExpenditure Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623/explain?concept=fundies%3ACapitalExpenditure&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 88932 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2608 The citation records this snapshot. The page link may show a newer release later.	−USD 1.67 million Calculation and evidence -1578160 − 88932 USD Exact free cash flow: -1667092 USD 2001-07-01 – 2002-06-30: -1578160 USD · Inspect Operating Cash Flow · Source 2001-07-01 – 2002-06-30: 88932 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERNATIONAL BIOCHEMICAL INDUSTRIES INC · 2002-06-30 INTERNATIONAL BIOCHEMICAL INDUSTRIES INC (edgar:1059623) Free cash flow: -1667092 USD Concept: free-cash-flow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1059623?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1578160 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2603 Input fundies:CapitalExpenditure: 88932 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1059623/0001161697-02-000296.txt#2608 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

22 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001059623, 1059623, edgar:1059623

Also known as BIOSHIELD TECHNOLOGIES INC

INTERNATIONAL BIOCHEMICAL INDUSTRIES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2002 2001-07-01 – 2002-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation